217 related articles for article (PubMed ID: 24357848)
1. Cystic fibrosis carrier screening in a North American population.
Zvereff VV; Faruki H; Edwards M; Friedman KJ
Genet Med; 2014 Jul; 16(7):539-46. PubMed ID: 24357848
[TBL] [Abstract][Full Text] [Related]
2. CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations.
Sugarman EA; Rohlfs EM; Silverman LM; Allitto BA
Genet Med; 2004; 6(5):392-9. PubMed ID: 15371903
[TBL] [Abstract][Full Text] [Related]
3. Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.
Palomaki GE; FitzSimmons SC; Haddow JE
Genet Med; 2004; 6(5):405-14. PubMed ID: 15371905
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis.
Strom CM; Crossley B; Buller-Buerkle A; Jarvis M; Quan F; Peng M; Muralidharan K; Pratt V; Redman JB; Sun W
Genet Med; 2011 Feb; 13(2):166-72. PubMed ID: 21068670
[TBL] [Abstract][Full Text] [Related]
5. Mutation distribution in expanded screening for cystic fibrosis: making up the balance in a context of ethnic diversity.
Schrijver I
Clin Chem; 2011 Jun; 57(6):799-801. PubMed ID: 21474640
[No Abstract] [Full Text] [Related]
6. The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients: Implications for Molecular Diagnostic Testing.
Schrijver I; Pique L; Graham S; Pearl M; Cherry A; Kharrazi M
J Mol Diagn; 2016 Jan; 18(1):39-50. PubMed ID: 26708955
[TBL] [Abstract][Full Text] [Related]
7. Cystic fibrosis carrier testing in an ethnically diverse US population.
Rohlfs EM; Zhou Z; Heim RA; Nagan N; Rosenblum LS; Flynn K; Scholl T; Akmaev VR; Sirko-Osadsa DA; Allitto BA; Sugarman EA
Clin Chem; 2011 Jun; 57(6):841-8. PubMed ID: 21474639
[TBL] [Abstract][Full Text] [Related]
8. Preconception and prenatal cystic fibrosis carrier screening of African Americans reveals unanticipated frequencies for specific mutations.
Monaghan KG; Bluhm D; Phillips M; Feldman GL
Genet Med; 2004; 6(3):141-4. PubMed ID: 15354332
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients.
Alper OM; Wong LJ; Young S; Pearl M; Graham S; Sherwin J; Nussbaum E; Nielson D; Platzker A; Davies Z; Lieberthal A; Chin T; Shay G; Hardy K; Kharrazi M
Hum Mutat; 2004 Oct; 24(4):353. PubMed ID: 15365999
[TBL] [Abstract][Full Text] [Related]
10. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel.
Heim RA; Sugarman EA; Allitto BA
Genet Med; 2001; 3(3):168-76. PubMed ID: 11388756
[TBL] [Abstract][Full Text] [Related]
11. Distribution of CFTR mutations in Saguenay- Lac-Saint-Jean: proposal of a panel of mutations for population screening.
Madore AM; Prévost C; Dorfman R; Taylor C; Durie P; Zielenski J; Laprise C
Genet Med; 2008 Mar; 10(3):201-6. PubMed ID: 18344710
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.
Watson MS; Cutting GR; Desnick RJ; Driscoll DA; Klinger K; Mennuti M; Palomaki GE; Popovich BW; Pratt VM; Rohlfs EM; Strom CM; Richards CS; Witt DR; Grody WW
Genet Med; 2004; 6(5):387-91. PubMed ID: 15371902
[No Abstract] [Full Text] [Related]
13. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients.
Pique L; Graham S; Pearl M; Kharrazi M; Schrijver I
Genet Med; 2017 Jan; 19(1):36-44. PubMed ID: 27148940
[TBL] [Abstract][Full Text] [Related]
14. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%.
Macek M; Mackova A; Hamosh A; Hilman BC; Selden RF; Lucotte G; Friedman KJ; Knowles MR; Rosenstein BJ; Cutting GR
Am J Hum Genet; 1997 May; 60(5):1122-7. PubMed ID: 9150159
[TBL] [Abstract][Full Text] [Related]
15. Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population.
Kornreich R; Ekstein J; Edelmann L; Desnick RJ
Genet Med; 2004; 6(5):415-20. PubMed ID: 15371906
[TBL] [Abstract][Full Text] [Related]
16. Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
Hughes EE; Stevens CF; Saavedra-Matiz CA; Tavakoli NP; Krein LM; Parker A; Zhang Z; Maloney B; Vogel B; DeCelie-Germana J; Kier C; Anbar RD; Berdella MN; Comber PG; Dozor AJ; Goetz DM; Guida L; Kattan M; Ting A; Voter KZ; ; van Roey P; Caggana M; Kay DM
Hum Mutat; 2016 Feb; 37(2):201-8. PubMed ID: 26538069
[TBL] [Abstract][Full Text] [Related]
17. Clinical diagnostic Next-Generation sequencing: the case of CFTR carrier screening.
Loukas YL; Thodi G; Molou E; Georgiou V; Dotsikas Y; Schulpis KH
Scand J Clin Lab Invest; 2015 Sep; 75(5):374-81. PubMed ID: 25874479
[TBL] [Abstract][Full Text] [Related]
18. Genomic sequencing in cystic fibrosis newborn screening: what works best, two-tier predefined CFTR mutation panels or second-tier CFTR panel followed by third-tier sequencing?
Currier RJ; Sciortino S; Liu R; Bishop T; Alikhani Koupaei R; Feuchtbaum L
Genet Med; 2017 Oct; 19(10):1159-1163. PubMed ID: 28471435
[TBL] [Abstract][Full Text] [Related]
19. Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk.
Lim RM; Silver AJ; Silver MJ; Borroto C; Spurrier B; Petrossian TC; Larson JL; Silver LM
Genet Med; 2016 Feb; 18(2):174-9. PubMed ID: 25880441
[TBL] [Abstract][Full Text] [Related]
20. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
